Study of Stepped Palliative Care in Patients With Advanced Lung Cancer DF/HCC SOCIAL-BEHAVIORAL RESERACH PROTOCOL
Stopped early · Not applicable
Conditions studied: Lung Cancer
In brief
This research study is evaluating a new way to provide palliative care to patients who have recently been diagnosed with lung cancer. . Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
Key facts
- Study ID
- NCT03220100
- Run by
- Massachusetts General Hospital
- People needed
- 11
- Starts
- 2017-07-18
- Expected to finish
- 2018-01-29
- Last updated by the study team
- 2019-03-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with advanced non-small cell lung cancer, small cell lung cancer, or mesothelioma, being treated with non-curative intent, and informed of advanced disease within the prior eight weeks
- Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 2 (symptomatic and in bed <50% of the day)
- The ability to read and respond to questions in English or with minimal help from a family member or medical interpreter.
- Primary cancer care at the MGH Cancer Center
- Age > 18 years
You may not qualify if…
- They are already receiving PC or hospice services
- They have cognitive or psychiatric conditions as determined by the treating oncologist that prohibits study consent or participation
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.